Endothelial adhesion molecule expression is enhanced in the aorta and internal mammary artery of diabetic patients

Journal of Surgical Research

Volumn 85, Issue 2, 1999, Pages 225-233

  Ribau, J C O ^a   Hadcock, S J ^a   Teoh, K ^a   DeReske, M ^a   Richardson, M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Bypass surgery; Diabetes mellitus; E selectin; Endothelium; ICAM 1; VCAM 1

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AORTA; ARTICLE; ATHEROSCLEROSIS; BYPASS SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNAL MAMMARY ARTERY; MALE; PRIORITY JOURNAL; RESTENOSIS; VASCULAR ENDOTHELIUM;

EID: 0032773115     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5682     Document Type: Article

References (55)

1. Garber A. J. Effective treatment of hypertension in patients with diabetes mellitus. Clin. Cardiol. 15:1992;715.
2. Levin M. E., Sicard G. A. Peripheral vascular disease in the person with diabetes. Rifkin H., Porte D. Jr. Diabetes Mellitus: Theory and Practice. 1990;768-791 Elsevier Science, New York.
3. Wagner O. F., Jilma B. Putative role of adhesion molecules in metabolic disorders. Horm. Metab. Res. 29:1997;627.
4. Patarroyo M., Makgoba M. W. Leukocyte adhesion to cells: Molecular basis, physiological relevance and abnormalities. Scan. J. Immunol. 30:1989;129.
5. Harlan J. M., Liu D. Y. Adhesion: Its Role in Inflammatory Disease. 1992;Freeman, New York. p. 1-15.
6. Cybulsky M. I., Gimbrone M. A. Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 251:1991;788.
7. O'Brien K. D., Allen M. D., McDonald T. O., Chait A., Harlan J. M., Fishbein D., McCarty J., Ferguson M., Hudkins K., Benjamin C. D. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. J. Clin. Invest. 92:1993;945.
8. Couffinhal T., Duplàa C., Moreau C., Lamazière J-M. D., Bonnet J. Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ. Res. 74:1994;225.
9. Bevilacqua M. P., Stengelin S., Gimbrone M. A. Jr., Seed B. Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 243:1989;1160.
10. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362:1993;801.
11. Haller H., Schaper D., Ziegler W., Philipp S., Kuhlmann M., Distler A., Luft F. C. Low-density lipoprotein induces vascular adhesion molecule expression on human endothelial cells. Hypertension. 25:1995;511.
12. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell. 62:1990;3.
13. Peter K., Nawroth P., Conradt C., Nordt T., Weissm T., Boehme M., Wunsch A., Allenberg J., Kübler W., Bode C. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intracellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler. Thromb. Vasc. Biol. 17:1997;505.
14. Ridker P. M., Hennekens C. H., Roitman-Johnson B., Stampfer M. J., Allen J. Plasma concentrations of soluble intercellular adhesion molecule-1 and risk of future myocardial infarction in apparently healthy men. Lancet. 351:1998;88.
15. Schmidt A., Crandall J., Hori O., Cao R., Lakatta E. Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) n diabetic patients with microalbuminaria: A marker of vascular dysfunction and progressive vascular disease. Br. J. Haematol. 92:1996;747.
16. Steiner M., Reinhardt M. K., Krammer B., Ernst B., Blann A. D. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thromb. Haemostas. 72:1994;979.
17. Cominacini L., Fratta A., Garbin U., Davoli A., De Santis A., Campagnola M., Rigoni A., Zenti M. G., Moghetti P., Lo Cascio V. Elevated levels of soluble E-Selectin in patients with IDDM and NIDDM: Relation to metabolic control. Diabetologia. 38:1995;1122.
18. Fasching P., Veitl M., Rohac M., Streli C., Schneider B., Waldhausl W., Wagner O. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 81:1996;4313.
19. Hadcock S., Richardson M., Winocour P. D., Hatton M. W. C. Intimal alterations in rabbit aortas during the first 6 months of alloxan-induced diabetes. Arterioscler. Thromb. 11:1991;517.
20. Richardson M., Hadcock S., DeReske M., Cybulsky M. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler. Thromb. 14:1994;760.
21. Drury R. A. B., Wallington E. A. Carleton's Histological Technique, 4th ed. 1967;Oxford Univ. Press, New York.
22. Mattson D. E. Statistics - Difficult Concepts, Understandable Explanations. 1981;Mosby, St. Louis.
23. Printseva O. Y., Peclo M. M., Gown A. M. Various cell types in human atherosclerotic lesions express ICAM-1. Am. J. Pathol. 140:1992;889.
24. Poston R. N., Haskard D. O., Coucher J. R., Gallm N. P., Johnson-Tidey R. R. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am. J. Pathol. 140:1992;665.
25. Davies M. J., Gordon J. L., Gearing A. J. H., Pigott R., Woolf N., Katz D., Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J. Pathol. 171:1993;223.
26. Duplàa C., Couffinhal T., Labat L., Moreau C., Petit-Jean M.-E., Doutre M.-S., Lamazière J.-M. D., Bonnet J. Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions. Atherosclerosis. 121:1996;253.
27. Gerstein H. C. Dysglycaemia: A cardiovascular risk factor. Diabetes Res. Clin. Pract. 40:1998;S9.
28. Schmidt A. M., Hori O., Chen J. X., Li J. F., Crandall J., Zhang J., Cao R., Yan S. D., Brett J., Stern D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: A potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 96:1995;1395.
29. Springer T. A. Adhesion receptors of the immune system. Nature. 346:1990;425.
30. Carlos T., Kovach N., Schwartz B., Rosa M., Newman B., Wayner E., Benjamin C., Osborn L., Lobb R., Harlan J. Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: Endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood. 77:1991;2266.
31. Kahn B. V., Parthasarathy S. S., Alexander R. W., Medford R. M. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest. 95:1995;1262.
32. Alderson L. M., Endmann G., Lindsey S., Pronczuk A., Hoover R. L., Hayes K. C. LDL enhances monocyte adhesion to endothelial cells in vitro. Am. J. Pathol. 123:1986;334.
33. Endemann G., Pronzcuk A., Friedman G., Lindsey S., Alderson L., Hayes K. C. Monocyte adherence to endothelial cells in vitro is increased by β-VLDL. Am. J. Pathol. 126:1987;1.
34. Moers A., Fenselau S., Schrezenmeir C. Chylomicrons induce E-selectin and VCAM-1 expression in endothelial cells. Diabetes. 105:1997;35.
35. Berliner J. A., Territo M. C., Sevanian A., Ramin S., Kim J. A., Bamshad B., Esterson M., Fogelman A. M. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1990;1260.
36. Tschoepe D. Adhesion molecules influencing atherosclerosis. Diabetes Res. Clin. Pract. 30:1996;19.
37. Tipping P. G., Hancock W. Production of tumor necrosis factor and interleukin-1 by macrophages from atheromatous plaques. Am. J. Pathol. 142:1993;1721.
38. Gamble J. R., Bradley S., Noack L., Vadas M. A. TGF-β and endothelial cells inhibit VCAM-1 expression on human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 15:1995;949.
39. Wang X., Feuerstein G. Z., Gu J.-L., Lysko P. G., Yue T.-L. Interleukin-1β induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells. Atherosclerosis. 115:1995;89.
40. Damle N. K., Aruffo A. Vascular cell adhesion molecule 1 induces T-cell antigen receptor-dependent activation of CD4+ T lymphocytes. Proc. Natl. Acad. Sci. USA. 88:1991;6403.
41. Jonasson L., Holm J., Skalli O., Bondjers G., Hansson G. K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 6:1986;131.
42. Gown A. Cell type and cell state specific antibodies in the analysis of early lesions of human atherosclerosis. Am. J. Hypertens. 5:1992;114S.
43. Stary H. C., Blankenhorn D. H., Chandler A. B., Glagov S., Insull W. Jr., Richardson M., Rosenfeld M. E., Schaffer S. A., Schwartz C. J., Wagner D. W., Wissler R. W. A definition of the intima of human arteries and of its atherosclerosis-prone regions. Arterioscler. Thromb. 12:1992;120.
44. Waller B. F., Palumbo P. J., Roberts W. C. Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years: Analysis of 229 patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am. J. Med. 69:1980;498.
45. Carrozza J. P. Jr., Kuntz R. E., Fishman R. F., Baim D. S. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann. Int. Med. 118:1993;344.
46. Stein B., Weintraub W. S., Gebhart S. S. P., Cohen-Bernstein C. L., Grosswald R., Liberman H. A., Douglas J. S. Jr., Morris D. C. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation. 91:1995;979.
47. Oikawa S., Hayasaka K., Hashizume E., Kotake H., Midorikawa H., Sekikawa A., Kikuchi A., Toyota T. Human arterial smooth muscle cell proliferation in human diabetes. Diabetes. 45:1996;S114.
48. Graier W. F., Grubenthal I., Dittrich P., Wascher T. C., Kostner G. M. Intracellular mechanism of high D-glucose-induced modulation of vascular cell proliferation. Eur. J. Pharmacol. 294:1995;221.
49. Stout R. Insulin as a mitogenic factor: Role in the pathogenesis of cardiovascular disease. Am. J. Med. 90:1991;62S.
50. Rumble J. R., Cooper M. E., Soulis T., Cox A., Wu L., Youssefs J. M., Jerums G., Gilbert R. E. Vascular hypertrophy in experimental diabetes. J. Clin. Invest. 99:1997;1016.
51. Iino K., Yoshinari M., Yamamoto M., Kaku K., Doi Y., Ichikawa K., Iwase M., Fujishima M. Effect of glycated collagen on proliferation of human smooth muscle cells in vitro. Diabetologia. 39:1996;800.
52. Ross R. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57:1995;791.
53. Menzel E. J., Neumuller J., Sengoelge G., Reihsner R. Effects of aminoguanidine on adhesion molecules expression of human endothelial cells. Pharmacology. 55:1997;126.
54. Dobrian A., Lazar V., Tirziu D., Simionescu M. Increased macrophage uptake of irreversibly glycated albumin modified-low density lipoprotein of normal and diabetic subjects is mediated by non-saturable mechanisms. Biochem. Biophys. Acta. 1317:1996;5.
55. Lopes-Virella M. F., Virella G. Modified lipoprotein, cytokines and macrovascular disease in non-insulin-dependent diabetes mellitus. Ann. Med. 28:1996;347.